Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin.
Paul
Simon
S
Javed
Usman
U
Tevendale
Robert
R
Lanford
Jill
J
Liu
Raymond
R
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D015658:HIV Infections / Q000150:complications*; D006470:Hemorrhage / Q000517:prevention & control; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D005169:Factor VIII; C100416:peginterferon alfa-2a